MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia

Radosław Chaber1,2, Artur Gurgul3, Jacek Tabarkiewicz1,4

  • 1Institute of Medical Sciences, Medical College of Rzeszów University, Poland.

Abstract

Insights

Aberrant DNA methylation disrupts microRNA expression in pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL). This study characterized the microRNA methylation landscape in BCP ALL, identifying specific methylation patterns and a TCF3-PBX1 genetic subtype subcluster.

Area of Science:

  • Genomics and epigenetics
  • Pediatric oncology
  • Molecular biology

Background:

  • Aberrant DNA methylation is a key mechanism disrupting microRNA (miRNA) expression in cancers.
  • B-cell precursor acute lymphoblastic leukemia (BCP ALL) is the most common pediatric malignancy, with altered miRNA expression patterns.
  • Understanding miRNA methylation is crucial for BCP ALL pathogenesis.

Purpose of the Study:

  • To comprehensively characterize the microRNA gene methylation profile landscape in pediatric BCP ALL patients.
  • To identify specific miRNA methylation signatures associated with BCP ALL.
  • To explore potential correlations between methylation patterns and BCP ALL subtypes or clinical features.

Main Methods:

  • Utilized Infinium® MethylationEPIC BeadChip Arrays for high-throughput methylation analysis.
  • Analyzed bone marrow samples from pediatric BCP ALL patients (n=38) and healthy controls (n=4).
  • Investigated differential methylation patterns across the miRNA geneome.

Main Results:

  • Identified significant differential methylation of miRNA genes in pediatric BCP ALL compared to controls.
  • Observed a distinct subcluster within BCP ALL patients characterized by the TCF3-PBX1 genetic subtype.
  • Found associations between hyper- and hypomethylated miRNA gene sites (promoters and gene bodies) and leukemia-related phenotypes. Top hypermethylated: MIR1273G, MIR1304, MIR663. Top hypomethylated: MIR4442, MIR155, MIR3909.

Conclusions:

  • Pediatric BCP ALL exhibits a distinct microRNA gene methylation landscape compared to non-neoplastic controls.
  • The TCF3-PBX1 genetic subtype forms a recognizable subcluster within BCP ALL based on methylation profiles.
  • Methylation patterns in miRNA genes are linked to leukemia-related phenotypes, highlighting their potential role in BCP ALL pathogenesis.